Geron Corporation, the pharmaceutical company based in Foster City, California, has disclosed a substantial restructuring plan that will involve laying... Read more
Tag: #Global Trends
Pharmaceutical Firm Introduces Dual-Action Therapy for Metabolic Conditions
Cipla Limited has unveiled a new medication, known as Yurpeak, which contains the active pharmaceutical ingredient tirzepatide. This injectable treatment... Read more
European Pharma Giants Sanofi and GSK Enter Preclinical Collaboration Deals
Rival European pharmaceutical companies Sanofi and GSK have both forged new partnership agreements aimed at strengthening their respective preclinical research... Read more
Novartis Reports Positive Phase III Trial Data for Ianalumab in Immune Thrombocytopenia
Novartis has announced favorable outcomes from the Phase III clinical trial VAYHIT2, which assessed the efficacy of ianalumab combined with... Read more
Paradigm Health Acquires Flatiron Clinical Research Arm, Raises $78M to Broaden Trial Access
Paradigm Health has completed the acquisition of Flatiron Health's clinical research business shortly after successfully raising $78 million in a... Read more
Eli Lilly Commits $6 Billion Investment for Major Pharmaceutical Manufacturing Hub in Alabama
The American pharmaceutical giant, Eli Lilly, has designated Huntsville, Alabama, as the location for its third manufacturing facility dedicated to... Read more
Relation Therapeutics and Novartis Launch Collaboration to Advance Atopic Disease Therapeutics
Relation Therapeutics has announced the formation of a multi-program, strategic alliance with Novartis with the aim of accelerating the development... Read more
Pfizer Accelerates Obesity Pipeline with New GLP-1 Acquisition
Licensing Agreement Details Pfizer, the U.S.-based pharmaceutical manufacturer, has signed an exclusive licensing deal with Yao Pharma—a subsidiary of Fosun... Read more
Relation Therapeutics and Novartis Launch Collaboration to Advance Atopic Disease Therapeutics
Relation Therapeutics has announced the formation of a multi-program, strategic alliance with Novartis with the aim of accelerating the development... Read more









